CML is a stem cell-derived disease and the accelerated development of CML due to Egr1 deficiency (Figure 2 & 3) prompted us to examine how the loss of Egr1 impacted leukemic stem/initiating cells (LSCs). Here, EGR1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.